Bayesian Capital Management’s Newmont NEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-31,350
Closed -$1.31M 928
2024
Q2
$1.31M Sell
31,350
-6,900
-18% -$282K 0.15% 178
2024
Q1
$1.37M Sell
38,250
-48,650
-56% -$1.68M 0.13% 215
2023
Q4
$3.6M Buy
86,900
+69,700
+405% +$2.69M 0.38% 56
2023
Q3
$636K Sell
17,200
-48,100
-74% -$1.96M 0.07% 316
2023
Q2
$2.79M Buy
65,300
+51,835
+385% +$2.35M 0.3% 78
2023
Q1
$660K Sell
13,465
-34,774
-72% -$1.69M 0.08% 320
2022
Q4
$2.28M Buy
48,239
+8,700
+22% +$388K 0.33% 50
2022
Q3
$1.66M Buy
39,539
+22,333
+130% +$1.04M 0.34% 66
2022
Q2
$1.03M Buy
+17,206
New +$1.22M 0.19% 147
2021
Q4
Sell
-8,600
Closed -$467K 471
2021
Q3
$467K Buy
+8,600
New +$507K 0.14% 197
2020
Q4
Sell
-24,300
Closed -$1.54M 603
2020
Q3
$1.54M Buy
+24,300
New +$1.58M 0.38% 62
2020
Q2
Sell
-4,800
Closed -$217K 688
2020
Q1
$217K Buy
+4,800
New +$217K 0.05% 565
2017
Q4
Sell
-32,200
Closed -$1.21M 660
2017
Q3
$1.21M Buy
+32,200
New +$1.17M 0.29% 105

Other funds holding NEM

Bayesian Capital Management's NEM Position: Q3 2024 in Review

Bayesian Capital Management sold out of Newmont (NEM) in Q3 2024, closing a stake of 31,350 shares — an estimated $1.31M sold.

Bayesian Capital Management first reported a position in NEM in Q3 2017 and held it in 13 quarters. The position peaked at $3.6M in Q4 2023. 1,245 funds tracked by Wall St. Rank hold NEM as of Q3 2024.

  • Bayesian Capital Management reported no remaining Newmont position as of Q3 2024 after selling out during the quarter.
  • Bayesian Capital Management sold 31,350 Newmont shares in Q3 2024, an estimated $1.31M.
  • Bayesian Capital Management first reported a position in Newmont in Q3 2017 and held it in 13 quarters.
  • Bayesian Capital Management's Newmont position peaked at $3.6M in Q4 2023.
  • 1,245 funds tracked by Wall St. Rank held Newmont as of Q3 2024.

Based on Bayesian Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.